Global positive airway pressure device market was valued at USD 1.75 billion in 2018. It is expected to continue growing at a rapid pace over the forecast period. Market growth can be attributed to the significant economic burden imposed by sleep apnea. The high economic burden of sleep apnea, which is linked to many health issues such as hypertension, heart disease and depression, indirectly increases the patient's overall economic burden. Untreated sleep apnea can lead to workplace accidents and productivity loss.
The American Academy of Sleep Medicine (AASM), in 2016, estimated that the annual economic impact of undiagnosed sleep apnea was USD 149.6 million. Treating sleep apnea could result in an economic saving of more than USD 100 billion annually in the country. This is why government institutions in different regions are focusing on improving the overall treatment rate. They also want to raise awareness about obstructive sleeping apnea among the population, thus increasing demand for positive airways pressure machines (PAP) worldwide.
To improve compliance rates, manufacturers of positive airway pressure devices are constantly innovating existing products. Competitors are focusing on creating more comfortable masks, with smaller breathing masks and better straps. These features have been able to increase patient compliance and improve PAP machine efficiency.
The market for PAP devices has also seen a rise in compliance rates. Around 80% opt for PAP therapy. Most insurance companies will only reimburse patients if they adhere to the prescribed time limits during the initial 90-day trial period. This helps patients to get compensation from their insurance providers. In turn, this supports the adoption of PAP devices.
The high price of PAP machines will likely hinder the market for positive airway pressure devices. The average price of a CPAP machine is USD 1000 to USD 4000 (without insurance), depending upon the brand, type of machine and features. While health insurance covers the cost for sleep apnea treatment costs, patients will need to pay a portion of the total cost. The new portable CPAP devices, which are lightweight and travel-friendly, have been launched on the market. They are therefore not covered by insurance.
The global market for PAP products can be divided into CPAP and APAP devices based on their product type. The market was dominated by CPAP devices in 2018, which generated a total revenue of USD 1.3 million. This market is expected to continue growing at a rapid pace over the forecast period. CPAP is often prescribed to patients suffering from obstructive sleeping apnea. These devices are also more popular than other PAP devices because they are less expensive.
Over the forecast period, the BiPAP device market is expected to grow at a rapid pace. Patients who have difficulty exhaling with CPAP devices should consider this device. This device is better than CPAP devices because it allows patients to breathe alternately and variable air flow. The accessibility to affordable reimbursement and the availability of technologically advanced products will be key factors driving this segment's growth over the forecast period.
The market for PAP devices can be divided by geography into North America (Europe, Asia Pacific and Latin America), Europe (Europe), Asia Pacific, Latin America and MEA. With a 47.4% revenue share, North America was the dominant market in 2018, and it is expected to continue growing at the fastest pace over the forecast period. The market for PAP devices is driven by the large number of patients suffering from sleep apnea. The American Sleep Association estimates that between 50 and 70 million Americans suffer from sleep disorders. Similar statistics are also found in Canada and other North American countries. Canadian Respiratory Journal reported that in 2014, 5.4 million Canadians were diagnosed with sleep disorder (or were at greater risk) of developing obstructive sleeping apnea (OSA).
The U.S. insurance companies have offered favorable reimbursement policies that have supported the growth in PAP devices in this area. In the U.S., for example, Medicare and private insurance companies will cover about 80% of the purchase price of a PAP device and all supplies. Patients have been encouraged to seek sleep apnea treatment. This has resulted in a significant rise in the use of PAP devices. Market growth will also be driven by the increasing prevalence of obesity and diabetes.
This market is highly competitive and consolidated, with only a few companies operating in it. Koninklijke Philips N.V., Philips Respironics; Curative Medical; ResMed, Fisher and Paykel Healthcare Limited, Drive DeVilbiss Healthcare Inc., and Somnetics International, Inc. are some of the market players. These companies focus on product development and strategic acquisitions. They also seek to develop partnerships that increase market share. The key players have a strong market presence, with a broad product portfolio and many distributors.
This report predicts revenue growth at the global, regional and country levels and offers an analysis of industry trends in each sub-segment from 2014 to 2025. Up Market Research has divided the global market for positive airway pressure devices by product type and location.
Product Type Outlook (Revenue USD Millions, 2014-2025)
CPAP
APAP
BiPAP
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Spain
France
Italy
Russia
Asia Pacific
China
Japan
India
South Korea
Singapore
Australia
Latin America
Brazil
Argentina
Mexico
MEA
South Africa
Saudi Arabia
UAE
Up Market Research published a new report titled “Positive Airway Pressure Devices Market research report which is segmented by Product Type (BiPAP, CPAP, APAP), By Players/Companies strategic acquisitions, Koninklijke Philips NV (Philips Respironics); Curative Medical; ResMed; Fisher and Paykel Healthcare Limited; Drive DeVilbiss Healthcare Inc; and Somnetics International, strong geographic presence in multiple countries, a wide product portfolio, developing partnerships to gain higher market share Moreover, Inc These companies are focused on new product development, a large number of distributors has helped the key players to strengthen their market presence”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Positive Airway Pressure Devices Market Research Report |
By Product Type | BiPAP, CPAP, APAP |
By Companies | strategic acquisitions, Koninklijke Philips NV (Philips Respironics); Curative Medical; ResMed; Fisher and Paykel Healthcare Limited; Drive DeVilbiss Healthcare Inc; and Somnetics International, strong geographic presence in multiple countries, a wide product portfolio, developing partnerships to gain higher market share Moreover, Inc These companies are focused on new product development, a large number of distributors has helped the key players to strengthen their market presence |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 207 |
Number of Tables & Figures | 145 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Product Type (BiPAP, CPAP, APAP).
Positive Airway Pressure Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Positive Airway Pressure Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Positive Airway Pressure Devices Market Report:
Some other reports from this category!